StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
PFSAProfusa, Inc.
stockpulse.co.kr
Nasdaq
$0.8103▼ 4.34%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $428,926.63Shares out 0.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

39
  • 10.15Pre-market26.10.15 19:10
    8-KKey event#●●●#●●●#●●●

    Profusa, Inc.Bullish

    Profusa has issued a senior secured convertible promissory note in the principal amount of $769,230.77 to Ascent Partners Fund LLC, raising $700,000 in gross proceeds. The note carries a 7% annual interest rate, a conversion price of $4.28 per share, and a floor price of $1.07. The company is required to begin monthly principal amortization payments starting January 1, 2027, which may be settled in common stock subject to certain equity payment conditions.…more

    $0.8103-4.34%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.9After-hours26.10.10 06:00
    8-KKey event

    Profusa, Inc.

    Profusa dismissed its independent registered public accounting firm, CBIZ CPAs P.C., on October 5, 2026, and engaged WithumSmith+Brown, PC as its new auditor on October 6, 2026. The company previously disclosed material weaknesses in internal control over financial reporting and substantial doubt regarding its ability to continue as a going concern, though no disagreements on accounting principles or auditing procedures were reported.…more

    $0.8103-4.34%vs prev close
    View filingShare
  • 10.5Pre-market26.10.05 19:07
    8-KKey event

    Profusa, Inc.

    Profusa entered into an amendment agreement with Ascent Partners Fund on October 4, 2026, regarding its existing convertible notes. The amendment modifies the conversion price calculation and sets a fixed floor price of $0.338 per share. Additionally, certain anti-dilution provisions for notes issued in August and September 2026 have been waived.…more

    $0.8103-4.34%vs prev close
    View filingShare

38 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.15Pre-market26.10.15 19:30
    #●●●#●●●

    Profusa Receives ISO 13485:2016 Certification

    Profusa has secured ISO 13485:2016 certification for its quality management system, a key requirement for medical device commercialization. This milestone supports the company's ongoing efforts to obtain CE marking for its Lumee Oxygen Platform in the European market.…more

    $0.8103-4.34%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 10.5Pre-market26.10.05 19:17

    ●●●●●●●● ●●●●● ●●●●●●

    Profusa has amended its securities purchase agreement regarding a $555,556 senior secured convertible promissory note. The adjustment to the conversion price calculation introduces potential for future equity dilution.…more

    $0.8103-4.34%vs prev close
    ShareBenzinga
  • 9.24Regular26.09.25 03:02

    ●●●●●●●● ●●●●● ●●●●●●

    Profusa has received ISO 13485 certification from GMED, marking progress toward obtaining the CE mark for its Lumee Oxygen Platform. While the company is advancing its regulatory goals, it noted that the final timeline for CE marking remains uncertain.…more

    $0.8103-4.34%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →